Skip to content

Study on the Value of 18F-FAPI-PET/CT in Accurate Evaluation of Systemic Sclerosis

Study on the Value of 18F-FAPI-PET/CT in Accurate Evaluation of Systemic Sclerosis

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500098083
Enrollment
Unknown
Registered
2025-03-03
Start date
2024-03-02
Completion date
Unknown
Last updated
2025-03-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Systemic Sclerosis

Interventions

Observation group:None

Sponsors

Peking University Third Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: (1) patients meets the criteria of 2013 American College of Rheumatology/European League of Rheumatology Associations (ACR/EULAR) SSc classification; (2) >= 18 years old.

Exclusion criteria

Exclusion criteria: (1) with a history of malignant tumors; (2) any history of bronchial artery embolism or massive hemoptysis (defined as acute bleeding>240mL within 24 hours or recurrent bleeding>100mL/day for several consecutive days); (3) an active hemoptysis or pulmonary hemorrhage, including events treated with bronchial artery embolization; (4) pregnant and lactating women; (5) pre-pregnancy in the future 3 months.

Design outcomes

Primary

MeasureTime frame
SUVmax;

Countries

China

Contacts

Public ContactRong Mu

Peking University Third Hospital

murongster@163.com+86 156 1190 8372

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026